ClinicalTrials.gov
ClinicalTrials.gov Menu

Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00577161
Recruitment Status : Terminated (closed to enrollment)
First Posted : December 19, 2007
Last Update Posted : September 22, 2008
Sponsor:
Information provided by:
CTI BioPharma

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : July 2012
  Estimated Study Completion Date : July 2012